Bluefin Capital Management’s uniQure QURE Stock Holding History

Bluefin Capital Management’s Portfolio QURE Stock Details QURE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Hold	0	–	–	–	255
2023 Q2	–	Hold	0	–	–	–	247
2023 Q1	–	Sell	-79,251	Closed	-$1.66M	–	83
2022 Q4	$1.8M	Buy	79,251 +11,370	+17%	+$245K	0.32%	57
2022 Q3	$1.27M	Buy	67,881 +15,689	+30%	+$330K	0.14%	113
2022 Q2	$964K	Sell	52,192 -2,331	-4%	-$37.1K	0.13%	137
2022 Q1	$985K	Buy	+54,523	New	+$952K	0.11%	127
2021 Q4	–	Sell	-14,505	Closed	-$464K	–	1106
2021 Q3	$464K	Sell	14,505 -15,856	-52%	-$483K	0.05%	291
2021 Q2	$935K	Sell	30,361 -400	-1%	-$13.4K	0.07%	195
2021 Q1	$1.04M	Sell	30,761 -28,706	-48%	-$1.03M	0.05%	191
2020 Q4	$2.15M	Buy	+59,467	New	+$2.51M	0.14%	101
2020 Q3	–	Sell	-124,692	Closed	-$5.11M	–	47
2020 Q2	$5.62M	Buy	124,692 +525	+0.4%	+$31K	0.55%	29
2020 Q1	$5.89M	Hold	124,167	–	–	1.01%	30
2019 Q4	$8.9M	Buy	124,167 +71,409	+135%	+$3.92M	0.65%	43
2019 Q3	$2.08M	Buy	+52,758	New	+$3.04M	0.34%	62
2018 Q4	–	Sell	-50,623	Closed	-$1.84M	–	542
2018 Q3	$1.84M	Buy	50,623 +42,003	+487%	+$1.56M	0.2%	116
2018 Q2	$326K	Buy	+8,620	New	+$276K	0.03%	248

Other funds holding QURE

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

683 Capital Management New York $1.08B AUM 85.52% 1-Year Est. Return

International Biotechnology Trust London, United Kingdom $297M AUM 17.25% 1-Year Est. Return

Pictet Asset Management

Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return